2018
Bock AS, Günther S, Mohr J, Goldberg LV, Jahic A, Klisch C, Hübner CA, Biskup S, Beetz C. A nonstop variant in REEP1 causes peripheral neuropathy by unmasking a 3'UTR-encoded, aggregation-inducing motif; Human Mutation; 2018; 39:193-196
Newton T, Allison R, Edgar JR, Lumb JH, Rodger CE, Manna PT, Rizo T, Kohl Z, Nygren AOH, Arning L, Schüle R, Depienne C, Goldberg L, Frahm C, Stevanin G, Durr A, Schöls L, Winner B, Beetz C* Reid E. Mechanistic basis of an epistatic interaction reducing age at onset in hereditary spastic paraplegia; Brain; 2018; 141:1286-1299
2017
Goos JAC, Swagemakers SMA, Twigg SRF, van Dooren MF, Hoogeboom AJM, Beetz C, Günther S, Magielsen FJ, Ockeloen CW, Ramos-Arroyo M, Pfundt R, Yntema HG, van der Spek PJ, Stanier P, Wieczorek D, Wilkie AOM, van den Ouweland AMW, Mathijssen IMJ, Hurst JA. (in press) Identification of causative variants in TXNL4A in Burn-McKeown Syndrome and isolated choanal atresia. European Journal of Human Genetics (accepted May 24th 2017).
Pathmanaban OM, Sadler KV, Kamaly-Asl ID, King AT, Rutherford SA, Hammerbeck-Ward C, McCabe MG, Kilday JP, Beetz C, Poplawski NK, Evans DG, Smith MJ. (in press) Association of genetic predisposition with solitary schwannoma or meningioma in chirldern and young adults. JAMA Neurology (accepted May 12th 2017).
Allison R, Edgar JR, Pearson G, Rizo T, Newton T, Günther S, Berner F, Hague J, Connel JW, Winkler J, Lippincott-Schwartz J, Beetz C, Winner B, Reid E. (2017) Coupling of endoplasmic reticulum to lysosome function reveals a unifying pathway for axonopathy. The Journal of Cell Biology 216:1337-1355.
Jahic A, Hinreiner S, Emberger W, Hehr U, Zuchner S, Beetz C. (2017) Doublet-mediated DNA rearrangement – a novel and potentially underestimated mechanism for the formation of recurrent pathogenic deletions. Human Mutation 38:275-278.
Breen C, Mercer J, Jones SA, Jahic A, Heptinstall L, Tylee K, Newman WG*, Beetz C*. (2016) Maternal mosaicism for IDUA deletion clarifies recurrence risk in MPS I. Human Genome Variation 3:16031. *equal contribution
2016
Harlalka GV*, McEntagart ME*, Gupta N*, Skrzypiec A*, Mucha M, Chioza BA, Simpson MA, Sreekantan-Nair A, Pereira A, Günther S, Jahic A, Modarres H, Moore-Barton H, Trembath RC, Kabra M, Baple EL, Thakur S, Patton MA, Beetz C#, Pawlak R, Crosby AH. (2016) Novel genetic, clinical and pathomechanistic insights into TFG-associated hereditary spastic paraplegia. Human Mutation 37:1157-1161. *equal contribution; # corresponding author
Meszarosova AU, Putzova M, Cermakova M, Vavrova D, Dolezalova K, Smetanova I, Stejskal D, Beetz C, Seeman P. (2016) SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia. Journal of Human Genetics 61:845-850.
Auer-Grumbach M, Toegel S, Schabhüttl M, Weinmann D, Chiari C, Bennett DLH, Beetz C, Klein D, Andersen P, Böhme I, Fink-Puches R, Gonzalez M, Harms MB, Motley W, Reilly MM, RennerW, Rudnik-Schöneborn S, Schlotter-WeigelB, Themistocleous AC, WeishauptJ, Wieland T, Tao F, Abreu L, WindhagerR, Zitzelsberger M, Strom TM, Walther T, Scherer SS, ZüchnerS, Martini R, Senderek J. (2016) Rare variants in MME, encoding metalloprotease neprilysin, are linked to late-onset autosomal dominant axonal polyneuropathies. American Journal of Human Genetics 99:607-623.
Jahic A, Erichsen AK, Deufel T, Tallaksen C, Beetz C. (in press) A polymorphic Alu insertion which mediates distinct disease associated deletions. European Journal of Human Genetics (accepted Feb 3rd 2016)
Hentschel J, Tatun D, Parkhomchuk D, Kurth I, Schimmel B, Heinrich-Weltzien R, Bertzbach S, Peters H, Beetz C. (2016) Identification of the first multi-exonic WDR72 deletion in isolated amelogenesis imperfecta, and generation of a WDR72-specific copy number screening tool. Gene 590:1-4.
Günther S, Elert-Dobkowska E, Söhn AS, Hinreiner S, Yoon G, Heller R, Hellenbroich Y, Hübner CA, Ray PN, Hehr U, Bauer P, Sulek A, Beetz C. (2016) High frequency of pathogenic rearrangements in SPG11, and extensive contribution of mutational hotspots and founder alleles. Human Mutation 37:703-709.
2015
Jahic A, Khundadze M, Jaenisch N, Schüle R, Klimpe S, Klebe S, Frahm C, Kassubek J, Stevanin G, Schöls L, Brice A, Hübner CA, Beetz C. (2015) The spectrum of KIAA0196 variants, and characterization of a murine knockout:implications for the mutational mechanism in hereditary spastic paraplegia type SPG8. Orphanet Journal of Rare Diseases 10:147-156.
Elert-Dobkowska E, Stepniak I, Krysa W, Rajkiewicz M, Rakowicz M, Rudzinska M, Wasielewska A, Pilch J, Kubalska J, Lipczynska-Lojkowska W, Kulczycki J, Kurdziel K, Beetz C, Zaremba J, Sulek A. (2015) Molecular spectrum of the SPAST, ATL1 and REEP1 genes mutations associated with the most common hereditary spastic paraplegias in a group of Polish patients. Journal of the Neurological Sciences 359:35-39.
Varga R*, Khundadze M*, Damme M, Nietzsche S, Hoffmann B, Stauber T, Koch N, Hennings JC, Franzka P, Huebner AK, Kessels MM, Biskup C, Jentsch TJ, Qualmann B, Braulke T, Kurth I, Beetz C, Hübner AC. (2015) In vivo Evidence for Lysosome Depletion and Impaired Autophagic Clearance in Hereditary Spastic Paraplegia Type SPG11. PLoS Genetics 11:e1005454. * equal contribution
Elert-Dobkowska E*, Henning JC*, Hübner CA, Beetz C. (in press) Multiplex ligation-dependent probe amplification for identification of correctly targeted murine embryonic stem cell clones. Anal Biochem 474:35-37.* equal contribution
Stuart HM, Roberts NA, Hilton EN, McKenzie EA, Daly SB, Hadfield KD, Rahal JS, Gardiner NJ, Tanley SW, Lewis MA, Sites E, Angle B, Alves C, Lourenco T, Rodrigues M, Calado A, Amado M, Guerreiro N, Serras I, Beetz C, Varga R, Silay MS, Darlow1 JM, Dobson MG, Barton DE, Hunziker M, Puri P, Feather SA, Goodship JA, Goodship THJ, Lambert HJ, Cordell HJ, the UK VUR Study Group, Saggar A, Kinali M, the 4C Study Group, Lorenz C, Moeller K, Schaefer F, Bayazit AK, Weber S, Newman WG, Woolf AS. (in press) Urinary tract effects of HPSE2 mutations in humans and mice. Journal of the American Society of Nephrology 26:797-804.
Smith MJ, Isidor B, Beetz C, Williams SG, Bhaskar SS, Richer W, O’Sullivan J, Anderson B, Daly SB, Urquhart JE, Fryer A, Rustad CF, Mills SJ, Samii A, du Plessis D, Halliday D, Barbarot S, Bordeaut F, Newman WG, Evans DG. (2015) Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis. Neurology 84:141-147.
Wieczorek D, Newman WG, Wieland T, Berulava T, Kaffe M, Falkenstein D, Beetz C, Graf E, Schwarzmayr T, Douzgou S, Clayton-Smith J, Daly SB, Williams SG, Bhaskar SS, Urquhart JE, Anderson B, O'Sullivan J, Boute O, Gundlach J, Czeschik JC, van Essen AJ, Hazan F, Park S, Hing A, Kuechler A, Lohmann DR, Ludwig KU, Mangold E, Steenpaß L, Zeschnigk M, Lemke J, Lourenco CM, Hehr U, Prott E, Waldenberger M, Böhmer AC, Horsthemke B, O’Keefe RT, Meitinger T, Burn J, Lüdecke H, StromTM. (2014) Compound heterozygosity of low-frequency promoter deletions and rare lossof-function mutations in TXNL4A alters spliceosome assembly and causes Burn-McKeown syndrome (BMKS). Am J Hum Genet 95:698-707.
2014
Jahic A, Kreuz F, Zacher P, Fiedler J, Bier A, Reif S, Rieger M, Krüger S, Beetz C, Plaschke J. (2014) A novel strumpellin mutation and potential pifalls in the molecular diagnosis of hereditary spastic paraplegia type SPG8. Journal of the Neurological Sciences 347:372-374.
Smith MJ, Beetz C, Williams SG, Bhaskar SB, O’Sullivan J, Anderson B, Daly SB, Urquhart JE, Bholah Z, Oudit D, Cheesman E, Kelsey A, McCabe MG, Newman WG, Evans DG. (2014) Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. Journal of Clinical Oncology 32:4155-4161.
Smith MJ, Wallace AJ, Bennett C, Hasselblatt M, Elert-Dobkowska E, Evans LT, Hickey WF, van Hoff J, Bauer D, Lee A, Hevner RF, Beetz C, du Plessis D, Kilday J, Newman WG, Evans DG. (in press) Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. Journal of Pathology 234:436-440.
Falk J, Rohde M, Bekhite MM, Neugebauer S, Hemmerich P, Kiehntopf M, Deufel T, Hübner CA, Beetz C. (2014) Functional mutation analysis provides evidence for a role of REEP1 in lipid droplet biology. Human Mutation 35:497-504.
Kornak U, Mademan I, Schinke M, Voigt M, Krawitz P, Hecht J, Barvencik F, Schinke T, Gießelmann S, Beil FT, Serradell AP, Vílchez JJ, Beetz C, Deconinck T, Timmerman V, Kaether C, De Jonghe P, Hübner CA, Gal A, Amling M, Mundlos S, Baets J, Kurth I. (in press) Sensory neuropathy with bone destruction due to a mutation in the membrane-shaping atlastin GTPase 3. Brain 137:683-692
Feierabend D, Walter J, Grube S, Herbold C, Beetz C, Kalff R, Ewald C (in press) Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in juvenile medulloblastomas. J Neuro-Oncol 116:213-220
2013
KhundadzeK, KollmannK, KochN, BiskupC, NietzscheS,ZimmerG, HenningsJC, HuebnerAK, SymmankJ, Jahic A, IlinaEI, KarleK, SchölsL, KesselsM, BraulkeT, QualmannB, KurthI, BeetzC, HübnerCA (in press) A hereditary spastic paraplegia mouse model reveals essential roles of ZFYVE26/SPASTIZIN for the endolysosomal system. PLoS Genetics 9:e1003988
BeetzC*, KochN*, KhundadzeM, ZimmerG, NietzscheS, HertelN, HuebnerAK, MumtazR, SchweizerM, DirrenE, KarleKN, IrintchevA, AlvarezV, RediesC, WestermannM, KurthI, DeufelT, KesselsMM, QualmannB, HübnerCA (2013) A spastic paraplegia mouse model reveals REEP1-dependent ER shaping. J Clin Invest 123:4273-4282.* equal contribution
Koehler K, Malik M, Mahmood S, Gießelmann S, Beetz C, Hennings JC, Huebner AK, Grahn A, Reunert J, Nürnberg G, Thiele H, Altmüller J, Nürnberg P, Mumtaz R, Babovic-Vuksanovic D, Basel-Vanagaite L, Borck G, Brämswig J, Mühlenberg R, Sarda P, Sikiric A, Anyane-Yeboa K, Zeharia A, Ahmad A, Coubes C, Wada Y, Marquardt T, Vanderschaeghe D, Van Schaftingen E, Kurth I, Huebner A, Christian A. Hübner CA (2013) Mutations in GMPPA cause a novel glycosylation disorder characterized by intelectual disability and autonomic dysfunction. Am J Hum Genet 93:727-734.
Varga RE, Schüle R, Fadel H, Valenzuela I, Speziani F, Gonzalez M, Rudenskaia G, Nürnberg G, Thiele H, Altmüller J, Alvarez V, Gamez J, Garbern JY, Nürnberg P, Zuchner S, Beetz C. (2013) Don’t trust the pedigree: reduced and sex-dependent penetrance at a novel mutation hotspot in ATL1 blurs autosomal dominant inheritance of spastic paraplegia. Human Mutation 34:860-863.
Beetz C, Johnson A, Schuh AL,Thakur S, Varga RE, Fothergill T, Hertel N, Bomba-Warczak E, Thiele H, Nürnberg G, Altmüller J, Saxena R, Chapman ER, Dent EW, Nürnberg P, Audhya A (2013) Inhibition of TFG function causes hereditary axon degeneration by impairing ER structure. PNAS 110:5091-5096.
Stuart HM, Roberts NA, Bergu B, Daly SB, Urquhart J, Bhaskar S, Dickerson JE, Mermerkaya M, Silay MS, Lewis MA, Olondriz MBO, Gener B, Beetz C, Varga RE, Gülpınar Ö, Süer E, Soygür T, Özçakar ZB, Yalçınkaya F, Kavaz A, Bulum B, Gücük A, Yue WW, Erdogan F, Berry A, Hanley NA, McKenzie EA, Hilton EN, Woolf AS, Newman WG (2013) LRIG2 mutations cause urofacial syndrome. Am J Hum Genet 92:259-264.
Sánchez-Ferrero E, Coto E, Beetz C, Gámez J, Corao AI, Díaz M, Esteban J, del Castillo E, Moris G, Infante J, Menéndez M, Pascual-Pascual SI, López de Munain A, Garcia-Barcina MJ, Alvarez V on behalf of the group for the study of the genetics of Spastic Paraplegia. (2013) SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet 83:257-262.
2012
Beetz C, Pieber T,Hertel N,Schabhüttl M, Fischer C, Trajanoski S, Graf E, Keiner S, Kurth I, Wieland T, Varga RE, Timmerman V, Reilly MM, Strom TM, Auer-Grumbach M (2012) Exome Sequencing Identifies a REEP1 Mutation Involved in Distal Hereditary Motor Neuropathy Type V. Am J Hum Genet 31:139-145.
Liebmann L, Beetz C, Thorwarth M, Deufel T, Hübner CA (2012) Morphological and electrophysiological features of mature neurons in differentiated skin-derived precursor cells. Journal of Stem Cells & Regenerative Medicine 8:35-36.
VargaRE, MumtazR, JahicA, RudenskayaGE, Sánchez-Ferrero E, Auer-GrumbachM, Hübner CA, Beetz C (2012) MLPA-based evidence for copy number gain: pitfalls in confirmation and necessity for exclusion of false positives. Anal Biochem 421:799-801.
Kiehntopf M*, Varga RE*, Koch HG, Beetz C (2012) A homemade MLPA assay detects known CTNS mutations and identifies an novel deletion in a previously unresolved cystinosis family. Gene 495:88-92. *equal contribution
Mahmood S*, Beetz C*, Tahir MM, Imran M, Mumtaz R, Bassmann I, Jahic A, Malik M, Nürnberg G, Hassan SAA, Rana R, Nürnberg P, Huebner CA (2012) First HPSE2 missense mutation in Urofacial Syndrome. Clin Genet 81:88-92. *equal contribution
2011
Schicks J, Synofzik M, Beetz C, Schiele F, Schöls F (2011) Mutations in the PDYN gene (SCA23) are not a frequent cause of dominant ataxia in Central Europe. Clin Genet 80:503-504.
Synofzik M*, Beetz C*, Bauer C, Bonin M, Sanchez-Ferrero E, Schmitz-Hübsch T, Wüllner U, Nägele T, Riess O, Schöls L, Bauer P (2011) Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features. J Med Genet 48:407-412. *equal contribution
Ishwinder K, Schramm G, Everts B, Scholzen T, Kindle KB, Beetz C, Montiel-Duarte C, Blindow S, Jones AT, Haas H, Stolnik S, Heery DM, Falcone FH (2011) Interleukin-4 Inducing Principle from Schistosoma mansoni Eggs (IPSE/alpha−1) contains a functional C-terminal nuclear localization signal necessary for nuclear translocation in mammalian cells but not for its uptake. Infection and Immunity 79:1779-1788.
2010
Bauer P*, Stevanin G*, Beetz C*, Synofzik M, Schmitz-Hübsch T, Wüllner U, Berthier E, Ollagnon-Roman E, Riess O, Forlani S, Mundwiller E, Durr A, Schöls L, Brice A (2010) Spinocerebellar ataxia type 11 (SCA11) is a rare cause of dominant ataxia in European patients. J Neurol Neurosurg Psychiatry 81:1229-1232. *equal contribution
Schlipf NA, Beetz C, Schüle R, Stevanin G, Erichsen AK, Forlani S, Zaros C, Karle K, Klebe S, Klimpe S, Durr A, Otto S, Tallaksen CM, Riess O, Brice A, Bauer P, Schöls L (2010) A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42) Eur J Hum Genet 18:1065-1067.
Alvarez V, Sánchez-Ferrero E, Beetz C, Díaz M, Alonso B, Corao AI, Gámez J, Esteban J, Gonzalo JF, Pascual-Pascual SI, López de Munain A, Moris G, Ribacoba R, Márquez C, Rosell J, Marín R, García-Barcina MJ, Del Castillo E, Benito C, Coto E; Group for the Study of the Genetics of Spastic Paraplegia (2010) Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurology 10:89.
Braschinsky M, Tamm R, Beetz C, Sanchez-Ferrero E, Raukas E, Lüüs SM, Gross-Paju K, Boillot C, Canzian F, Metspalu A, Haldre S (2010) Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements. BMC Neurology 10:17.
2009
Murphy S, Gorman G, Beetz C, Byrne P, Dytko M, McMonagle P, Farrell M, Hutchinson M (2009) Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic and neuropathological evidence. Neurology 73:378-384.
Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M, Forlani S, Guyant-Maréchal L, Fontaine B, Guimarães J, Isidor B, Chazouillères O, Wendum D, Grid D, Chevy F, Chinnery PF, Coutinho P, Azulay JP, Feki I, Mochel F, Wolf C, Mhiri C, Crosby A, Brice A, Stevanin G (2009) CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain 132:1589-1600.
Schule R, Brandt E, Karle KN, Tsaousidou M, Klebe S, Klimpe S, Auer-Grumbach M, Crosby AH, Hübner CA, Schöls L, Deufel T, Beetz C (2009) Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia. Neurogenetics 10:97-104.
2008
Ewald C, Hofmann T, Kuhn SA, Deufel T, Beetz C, Kalff R (2008) Methylation-specific multiplex ligation-dependent probe amplification in meningiomas. J Neurooncol 90:267-273.
Beetz C*, Schule R*, Deconinck T*, Tran-Viet KN, Zhu H, Kremer BP, Frints SG, van Zelst-Stams WA, Byrne P, Otto S, Nygren AO, Baets J, Smets K, Ceulemans B, Dan B, Nagan N, Kassubek J, Klimpe S, Klopstock T, Stolze H, Smeets HJ, Schrander-Stumpel CT, Hutchinson M, van de Warrenburg BP, Braastad C, Deufel T, Pericak-Vance M, Schols L, de Jonghe P, Zuchner S (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131:1078-1086. *equal contribution
Beetz C, Schule R, Klebe S, Klimpe S, Klopstock T, Lacour A, Otto S, Sperfeld AD, van de Warrenburg B, Schols L, Deufel T (2008) Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots. J Neurol Sci 268:131-135.
2007
Beetz C, Nygren AO, Deufel T, Reid E (2007) An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion. Neurogenetics 8:317-318.
SchickelJ, PammingerT, EhrsamA, MünchS, HuangX, KlopstockT, KurlemannG, HemmerichP, DubielW, DeufelT, Beetz C (2007) Isoform-specific increase of spastins stability by N-terminal missense variants including intragenic modifiers of SPG4 hereditary spastic paraplegia. Eur J Neurol 14:1322-1388.
Mitne-Neto M*, Kok F*, Beetz C*, PessoaA, BuenoC, GracianiZ, MartynM, MonteiroCBM, MitneG, HubertP, NygrenAOH, ValadaresM, CerqueiraAMP, StarlingA, DeufelT, ZatzM (2007) A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigree. Eur J Hum Genet 15:1276-1279. *equal contribution.
Djarmati A, Guzvic M, Grunewald A, Lang AE, Pramstaller PP, Simon DK, Kaindl AM, Vieregge P, Nygren AO, Beetz C, Hedrich K, Klein C (2007) Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 22:1708-1714.
Beetz C, Zuchner S, Ashley-Koch A, Auer-Grumbach M, Byrne P, Chinnery PF, Hutchinson M, McDermott CJ, Meijer IA, Nygren AO, Pericak-Vance M, Pyle A, Rouleau GA, Schickel J, Shaw PJ, Deufel T (2007) Linkage to a known gene but no mutation identified: comprehensive reanalysis of SPG4 HSP pedigrees reveals large deletions as the sole cause. Hum Mutat 28: 739-40.
Kuhn SA, Hanisch UK, Ebmeier K, Beetz C, Brodhun M, Reichart R, Ewald C, Deufel T, Kalff R (2007) A paediatric supratentorial primitive neuroectodermal tumour associated with malignant astrocytic transformation and a clonal origin of both components. Neurosurg Rev 30: 143-9.
2006
Beetz C, Bergner S, Brodoehl S, Brodhun M, Ewald C, Kalff R, Kruger J, Patt S, Kiehntopf M, Deufel T (2006) Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology. Int J Oncol 29: 1183-91.
Beetz C*, Nygren AO*, Schickel J, Auer-Grumbach M, Burk K, Heide G, Kassubek J, Klimpe S, Klopstock T, Kreuz F, Otto S, Schule R, Schols L, Sperfeld AD, Witte OW, Deufel T (2006) High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 67: 1926-30. *equal contribution.
Schickel J, Beetz C, Frommel C, Heide G, Sasse A, Hemmerich P, Deufel T (2006) Unexpected pathogenic mechanism of a novel mutation in the coding sequence of SPG4 (spastin). Neurology 66: 421-3.
2005
Beetz C, Brodoehl S, Patt S, Kalff R, Deufel T (2005) Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma. Oncol Rep 13: 335-40.
2004
Beetz C, Brodhun M, Moutzouris K, Kiehntopf M, Berndt A, Lehnert D, Deufel T, Bastmeyer M, Schickel J (2004) Identification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter system. Biochem Biophys Res Commun 318: 1079-84.
Beetz C, Hartmann A, Kiehntopf M, Wolfl S, Kalff R, Deufel T, Patt S (2004) Rapid generation of detailed loss of heterozygosity profiles for routine diagnosis of gliomas. Clin Chem Lab Med 42: 595-601.
Patt S, Preussat K, Beetz C, Kraft R, Schrey M, Kalff R, Schonherr K, Heinemann SH (2004) Expression of ether a go-go potassium channels in human gliomas. Neurosci Lett 368: 249-53.
Thomsen S, Till A, Wittlieb J, Beetz C, Khalturin K, Bosch TC (2004) Control of foot differentiation in Hydra: in vitro evidence that the NK-2 homeobox factor CnNK-2 autoregulates its own expression and uses pedibin as target gene. Mech Dev 121: 195-204.
2003
Preussat K, Beetz C, Schrey M, Kraft R, Wolfl S, Kalff R, Patt S (2003) Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci Lett 346: 33-6.
2002
Schrey M, Codina C, Kraft R, Beetz C, Kalff R, Wolfl S, Patt S (2002) Molecular characterization of voltage-gated sodium channels in human gliomas. Neuroreport 13: 2493-8.